• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Spectrum of Epstein-Barr virus-associated diseases in allogeneic hematopoietic stem cell transplanta

Spectrum of Epstein-Barr virus-associated diseases in allogeneic hematopoietic stem cell transplanta

来源 :广东省医学会第十七次血液病学学术会议 | 被引量 : 0次 | 上传用户：lg7519
【摘 要】
：
Background: Epstein-Barr virus (EBV) infection may result in a spectrum of diseases in recipients of allogeneic hematopoietic stem cell transplantation (allo-HSCT), including fever, post-transplant ly
【作 者】
：
Li Xuan Xinmiao Jiang Jing Sun Yu Zhang Fen Huang Zhiping Fan Xutao Guo Min Dai Can Liu Guopan Yu Xian Zhang Meiqing Wu Qifa Liu 
【机 构】
：
Department of Hematology, Nanfang Hospital, Southern Medical University,Guangzhou 510515, China
【出 处】
：
广东省医学会第十七次血液病学学术会议
【发表日期】
：
2013年12期
【关键词】
：
spectrum Epstein-Barr virus-associated disease rituximab allogeneic hematopoieti 
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
　　Background: Epstein-Barr virus (EBV) infection may result in a spectrum of diseases in recipients of allogeneic hematopoietic stem cell transplantation (allo-HSCT), including fever, post-transplant lymphoproliferative diseases (PTLD) and endorgan diseases (pneumonia, encephalitis/myelitis, hepatitis and so on).Now PTLD has been widely studied; however, there are only scattered reports about EBV-associated diseases other than PTLD.Aims: To investigate the incidence, clinical characteristics and prognosis of the spectrum of EBV-associated diseases.Methods: A total of 263 recipients undergoing allo-HSCT were enrolled.
其他文献
has-miRNA-200家族在上皮性卵巢癌中的表达及其临床意义
目的 检测人类微小RNA-200(简称has-miRNA-200)家族在上皮性卵巢癌组织中的表达情况及其与上皮性卵巢癌的发生、发展关系.方法 采用茎环实时定量荧光逆转录聚合酶链反应(real-time Quantitative PCR)检测2010年10月至2011年5月在广东省人民医院的35例上皮性卵巢癌、15例上皮性良性卵巢肿瘤及10例正常卵巢组织中has-miRNA-200a、has-miR
会议
TDH(-470G>A)多态性降低卵巢癌发病风险
目的 卵巢癌是女性生殖系统恶性肿瘤中死亡率最高的的疾病,寻找鉴定卵巢癌高危人群和卵巢癌患者分子分型的分子标记,对于高危人群或易感个体早诊、早治,实施有效的干预措施具有重要意义.据报道有超过200个候选基因和20个遗传区域的1100个遗传变异与卵巢癌易感性相关,但是与卵巢癌相关性很强的遗传变异却很少,因此需要进一步寻找和识别卵巢癌易感基因.MTDH的高表达与肿瘤发生、浸润、侵袭、进展、血管生成、上皮
会议
High density of IL-17-producing cells is associated with improved prognosis for advanced epithelial
Objectiyes Interleukin(IL)-17 is the signature cytokine of T helper 17 cells.The role of IL-17 in the tumor microenvironment is still controversial.Few studies describing IL-17 expression in ovarian c
会议
MIIP对子宫内膜癌转移的抑制作用及其机制研究
目的 子宫内膜癌(endometrial carcinoma,EC)为常见的妇科恶性肿瘤,其发病率呈逐年上升趋势.侵袭转移的发生是内膜癌患者死亡的主要原因,因此抑制内膜癌侵袭转移是提高内膜癌患者生存率的关键.迁移侵袭抑制蛋白(Migration and Invasion Inhibitory Protein,MIIP)基因为新发现的候选抑癌基因,位于1p36,该区在包括子宫内膜癌在内的多种肿瘤中缺
会议
Gankyrin plays an essential role in estrogen-driven and GPR30-mediated endometrial carcinoma cell pr
Objective To elucidate the mechanisms of Gankyrin in estrogen-driven and GPR30-mediated endometrial carcinoma cell proliferation,analyze the relationship between the protein levels of Gankyrin and PTE
会议
Impact of Preoperative Platelet Count on Cervical Involvement of Patients with Endometrioid Endometr
Objective Although thrombocytosis has been reported in patients with various cancers,the association between thrombocytosis and the clinicopathological factors of patients with endometrial cancer has
会议
Notch-RBP-J signaling is required by bone marrow stromal cells for the treatment of acute graft vers
Recent evidence has shown that bone marrow stromal cells (BMSCs) may exhibit immuno-suppression activities through soluble mediators and direct cell-to-cell contact, but how these processes are modula
会议
bone marrow stromal cellsNotch signalingaGvHDdendritic cellsT-cells
万珂联合地塞米松治疗心脏原发系统性淀粉样变性的疗效分析
目的：评估万珂联合地塞米松治疗心脏原发系统性淀粉样变性的疗效.方法：回顾性分析从2006年03月至2011年8月所有在中山大学附属第一医院确诊为系统性淀粉样变性的患者的预后.患者分为万珂联合地塞米松(VD)治疗组和无治疗组.比较两组患者的血液学、器官缓解效果以及追踪患者的生存情况.结果：10例接受VD方案化疗患者的血液学总体缓解率为80％，其中完全缓解5例，部分缓解为3例.VD方案治疗血液学缓解起
会议
Comparison of mesenchymal stem cells and mesenchymal stem cells combined with cord blood for treatme
Background: Engraft failure after autologous hematopoietic stem cell transplantation (auto-HSCT) is a formidable complication which occurs in 2.0-9.5% of patients and is associated with considerable m
会议
Mesenchymal stem cell as a salvage treatment for severe refractory acute graft-versus-host disease:
Background: Refractory acute graft versus host disease (aGVHD) is one of the major causes of death after allogenetic haematopoietic stem cell transplantation (allo-HSCT).Aims: This study evaluated the
会议
graft-versus-host diseasemesenchymal stem cellhematopoietic stem cell transpla